ArticleFrontiers in oncology2024

RFWD3 modulates response to platinum chemotherapy and promotes cancer associated phenotypes in high grade serous ovarian cancer.

Sarah J Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.